Review



bca commercial assay kit  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Thermo Fisher bca commercial assay kit
    Bca Commercial Assay Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bca commercial assay kit/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    bca commercial assay kit - by Bioz Stars, 2026-06
    99/100 stars

    Images



    Similar Products

    99
    Thermo Fisher bca commercial assay kit
    Bca Commercial Assay Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bca commercial assay kit/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    bca commercial assay kit - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    96
    Thermo Fisher paraformaldehyde thermo fisher scientific j19943 k2 commercial assays bca protein assay kit thermo fisher scientific 23225 e z n a
    Paraformaldehyde Thermo Fisher Scientific J19943 K2 Commercial Assays Bca Protein Assay Kit Thermo Fisher Scientific 23225 E Z N A, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/paraformaldehyde thermo fisher scientific j19943 k2 commercial assays bca protein assay kit thermo fisher scientific 23225 e z n a/product/Thermo Fisher
    Average 96 stars, based on 1 article reviews
    paraformaldehyde thermo fisher scientific j19943 k2 commercial assays bca protein assay kit thermo fisher scientific 23225 e z n a - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    99
    Thermo Fisher bca protein assay commercial kit
    Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using <t>the</t> <t>colorimetric</t> <t>bicinchoninic</t> <t>acid</t> <t>assay.</t> ** 0.01 < p < 0.05.
    Bca Protein Assay Commercial Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bca protein assay commercial kit/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    bca protein assay commercial kit - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher bicinchoninic acid bca protein assay kit thermo scientific 23225 commercial assay
    Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using <t>the</t> <t>colorimetric</t> <t>bicinchoninic</t> <t>acid</t> <t>assay.</t> ** 0.01 < p < 0.05.
    Bicinchoninic Acid Bca Protein Assay Kit Thermo Scientific 23225 Commercial Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bicinchoninic acid bca protein assay kit thermo scientific 23225 commercial assay/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    bicinchoninic acid bca protein assay kit thermo scientific 23225 commercial assay - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    86
    Changsheng Bio Technology Co bca commercial kit
    Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using <t>the</t> <t>colorimetric</t> <t>bicinchoninic</t> <t>acid</t> <t>assay.</t> ** 0.01 < p < 0.05.
    Bca Commercial Kit, supplied by Changsheng Bio Technology Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bca commercial kit/product/Changsheng Bio Technology Co
    Average 86 stars, based on 1 article reviews
    bca commercial kit - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    99
    Thermo Fisher bca commercial kit
    Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using <t>the</t> <t>colorimetric</t> <t>bicinchoninic</t> <t>acid</t> <t>assay.</t> ** 0.01 < p < 0.05.
    Bca Commercial Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bca commercial kit/product/Thermo Fisher
    Average 99 stars, based on 1 article reviews
    bca commercial kit - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    90
    Thermo Fisher commercial kit based on the bicinchoninic acid methodology (bca)
    Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using <t>the</t> <t>colorimetric</t> <t>bicinchoninic</t> <t>acid</t> <t>assay.</t> ** 0.01 < p < 0.05.
    Commercial Kit Based On The Bicinchoninic Acid Methodology (Bca), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/commercial kit based on the bicinchoninic acid methodology (bca)/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    commercial kit based on the bicinchoninic acid methodology (bca) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Beyotime commercial bicinchoninic acid (bca) protein assay kit
    Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using <t>the</t> <t>colorimetric</t> <t>bicinchoninic</t> <t>acid</t> <t>assay.</t> ** 0.01 < p < 0.05.
    Commercial Bicinchoninic Acid (Bca) Protein Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/commercial bicinchoninic acid (bca) protein assay kit/product/Beyotime
    Average 90 stars, based on 1 article reviews
    commercial bicinchoninic acid (bca) protein assay kit - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using the colorimetric bicinchoninic acid assay. ** 0.01 < p < 0.05.

    Journal: International Journal of Molecular Sciences

    Article Title: A Deletion Variant of Human Factor VIII Displaying Low Immunogenicity in a Murine Model of Hemophilia A

    doi: 10.3390/ijms262412093

    Figure Lengend Snippet: Purity, structural integrity analysis, and specific activity of the recombinant Factor VIII produced in our laboratory (rhFVIII-H6A) compared to reference commercial products. ( A ) Factor VIII light chain (LCh) Western blot analysis of the pool of samples derived from media conditioned by the H6A cell clone (well 2) (0.04 IU); after the anion exchange chromatography step (well 3) (0.07 IU); after the affinity chromatography step (well 4) (0.13 IU); retained fractions after the 100 kDa ultrafiltration step (well 5) (0.49 IU); rhFVIII-H6A final formulation (well 6) (0.5 IU); recombinant product Kogenate ® FS (well 7) (0.5 IU); and plasma derived Fanhdi ® (well 9) (0.5 IU). Water in well number 8. ( B ) Evaluation of the protein mixture complexity was carried out for the same samples described in ( A ) using 8% denaturing polyacrylamide gel electrophoresis, followed by staining with Coomassie blue G-250 colloidal using 2 IU of formulated rhH6A (well 6); a total of 2 IU of rhFVIII Kogenate ® FS (well 7) and 1 IU pdFVIII Fanhdi ® (well 9). Molecular weight ladder was applied in well number 1. ( C ) Factor VIII specific activity obtained for formulated rhFVIII-H6A. Specific activity was quantified based on the chromogenic in vitro Factor VIII activity assay and protein quantification using the colorimetric bicinchoninic acid assay. ** 0.01 < p < 0.05.

    Article Snippet: Total protein was quantified using the colorimetric assay based on bicinchoninic acid, namely the BCA Protein Assay commercial kit (Lot CI48587) from Pierce (ThermoFisher Scientific, Rockford, IL, USA), following the manufacturer’s instructions.

    Techniques: Activity Assay, Recombinant, Produced, Western Blot, Derivative Assay, Chromatography, Affinity Chromatography, Formulation, Clinical Proteomics, Polyacrylamide Gel Electrophoresis, Staining, Molecular Weight, In Vitro, Acid Assay